JPH06507903A - 複数層の制御放出処方剤 - Google Patents
複数層の制御放出処方剤Info
- Publication number
- JPH06507903A JPH06507903A JP5500289A JP50028993A JPH06507903A JP H06507903 A JPH06507903 A JP H06507903A JP 5500289 A JP5500289 A JP 5500289A JP 50028993 A JP50028993 A JP 50028993A JP H06507903 A JPH06507903 A JP H06507903A
- Authority
- JP
- Japan
- Prior art keywords
- beads
- drug
- acid
- compound
- bead
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Description
Claims (23)
- 1.1)複数層コアと、2)複数層周辺部とからなる成分を含めてなる制御され た放出の薬剤ビーズであって、上記のコアは、少なくとも(A)適当なヒドロカ ルビルまたは置換ヒドロカルビルカルボン酸を有する内部と、(B)該内部を覆 う持続的酸放出被膜とを含有し、上記の周辺部は、少なくとも(A)少なくとも (i)薬剤化合物および(ii)表面活性剤の混合物を有する内部と、(B)そ の上の持続的薬剤放出被膜とを含有し、上記のビーズが適当な水性媒体中で、一 般的にpHに依存しない薬剤化合物の制御された放出に有効である量の上記の成 分を有している場合の薬剤ビーズ。
- 2.上記の周辺部が適当なヒドロカルビルまたは置換ヒドロカルビルカルボン酸 を含有している、請求項1のビーズ。
- 3.上記の酸がアルキルまたは置換アルキルカルボン酸である、請求項1のビー ズ。
- 4.上記の酸がアルキルまたは置換アルキルカルボン酸である、請求項2のビー ズ。
- 5.上記の酸が同じものである、請求項4のビーズ。
- 6.上記の酸がコハク酸である、請求項5のビーズ。
- 7.上記の薬剤化合物が弱塩基である、請求項1のビーズ。
- 8.上記の薬剤化合物がベンゾチアゼビン化合物である、請求項1のビーズ。
- 9.上記のベンゾチアゼビン化合物がクレンチアゼムである、請求項8のビーズ 。
- 10.上記の表面活性剤がラウリル硫酸ナトリウムである、請求項1のビーズ。
- 11.上記の持続的薬剤放出被膜が、予め選択された時間的遅れに続いて、水性 媒体中で上記の薬剤化合物の急速放出を可能とする、請求項1のビーズ。
- 12.適当なヒドロカルビルまたは置換ヒドロカルビルカルボン酸を含有する内 部コアをつくり、複数層コアを提供するために、これを持続的酸放出被膜で覆い 、上記のコアの上に、少なくとも一つの薬剤化合物と一つの表面活性剤との混合 物からなる内側周辺部をつくり、これを持続的薬剤放出被膜で覆うことを含めて なる、制御放出用薬剤ビーズの製法。
- 13.上記の周辺部が適当なヒドロカルビルまたは置換ヒドロカルビルカルボン 酸を含有する、請求項12のビーズ。
- 14.上記の酸がアルキルまたは置換アルキルカルボン酸である、請求項12の ビーズ。
- 15.上記の酸がアルキルまたは置換アルキルカルボン酸である、請求項13の ビーズ。
- 16.上記の酸が同じものである、請求項15のビーズ。
- 17.上記の酸がコハク酸である、請求項16のビーズ。
- 18.上記の薬剤化合物が弱塩基である、請求項12のビーズ。
- 19.上記の薬剤化合物がベンゾチアゼピン化合物である、請求項12のビーズ 。
- 20.上記のベンゾチアゼビン化合物がクレンチアゼムである、請求項19のビ ーズ。
- 21.上記の表面活性剤がラウリル硫酸ナトリウムである、請求項12のビーズ 。
- 22.上記の持続的薬剤放出被膜が、予め選択された時間的遅れに続いて、水性 媒体中で上記の薬剤化合物の急速放出を可能とする、請求項12のビーズ。
- 23.一般的にpHに依存しない制御された薬剤化合物の放出が行なわれるよう に、請求項1の制御放出用薬剤ビーズのサシプルを経口摂取させることを含めて なる、薬剤化合物を患者に投与する方法。 1 国際出願番号 PCT/1Js921042672 M明CD−ZTh オ ノ翫ニー島iよ、1□ゎ、ヵ□13 特許出願人 住 所 アメリカ合衆国 64114−0480 ミズーリ州 カンザスシティ ー ビー、オー ホックス 8480 ワード バークウェイ 9300 名称(氏名) マリオン ラボラトリーズ イシコーボしイテゾト(ほか1名) 4代理人 住 所 東京都新宿区新宿2丁目 8番3号新宿セブンヒル503号6 λ会 1寸 書 項 1 補正書の写し、(訓訳文) 1通
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70285491A | 1991-05-20 | 1991-05-20 | |
US702,854 | 1991-05-20 | ||
PCT/US1992/004267 WO1992020326A1 (en) | 1991-05-20 | 1992-05-20 | Multi-layered controlled release formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06507903A true JPH06507903A (ja) | 1994-09-08 |
JP3426230B2 JP3426230B2 (ja) | 2003-07-14 |
Family
ID=24822867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50028993A Expired - Lifetime JP3426230B2 (ja) | 1991-05-20 | 1992-05-20 | 複数層の制御放出処方剤 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5320853A (ja) |
EP (1) | EP0585355B1 (ja) |
JP (1) | JP3426230B2 (ja) |
AT (1) | ATE120089T1 (ja) |
AU (1) | AU2016992A (ja) |
DE (1) | DE69201793T2 (ja) |
DK (1) | DK0585355T3 (ja) |
ES (1) | ES2073301T3 (ja) |
GR (1) | GR3015737T3 (ja) |
NZ (1) | NZ242806A (ja) |
WO (1) | WO1992020326A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996019974A1 (fr) * | 1994-12-27 | 1996-07-04 | Kanebo, Ltd. | Preparation a liberation prolongee |
JP2007510676A (ja) * | 2003-11-13 | 2007-04-26 | レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 作用物質放出に関して調節作用のある物質を含有する、多層の剤形 |
JP2007510677A (ja) * | 2003-11-13 | 2007-04-26 | レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 調節性の物質の放出に影響を及ぼすマトリックスを有する多層の剤形 |
JP2009524698A (ja) * | 2006-01-27 | 2009-07-02 | ユーランド,インコーポレイテッド | 弱塩基性薬および有機酸を含む薬物送達系 |
JP2009524697A (ja) * | 2006-01-27 | 2009-07-02 | ユーランド,インコーポレイテッド | 弱塩基性選択性セロトニン5−ht3遮断剤および有機酸を含む薬物送達系 |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU653026B2 (en) * | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
EP0804174A4 (en) * | 1993-07-21 | 1998-09-09 | Univ Kentucky Res Found | MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS |
US5395626A (en) * | 1994-03-23 | 1995-03-07 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
US5645858A (en) * | 1994-10-06 | 1997-07-08 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
US5834024A (en) | 1995-01-05 | 1998-11-10 | Fh Faulding & Co. Limited | Controlled absorption diltiazem pharmaceutical formulation |
FR2754177B1 (fr) * | 1996-10-07 | 1999-08-06 | Sanofi Sa | Microspheres pharmaceutiques d'acide valproique pour administration orale |
US5885616A (en) * | 1997-08-18 | 1999-03-23 | Impax Pharmaceuticals, Inc. | Sustained release drug delivery system suitable for oral administration |
US6602521B1 (en) | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
KR101216270B1 (ko) | 1999-10-29 | 2012-12-31 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
US7220430B2 (en) | 2000-01-27 | 2007-05-22 | Tanabe Seiyaku Co., Ltd. | Sustained-release preparation and process for producing the same |
US6635277B2 (en) | 2000-04-12 | 2003-10-21 | Wockhardt Limited | Composition for pulsatile delivery of diltiazem and process of manufacture |
AU2002227383B2 (en) | 2000-10-30 | 2004-07-08 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
GB0310919D0 (en) * | 2003-05-13 | 2003-06-18 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
ES2228267B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
ES2228268B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
JP4468669B2 (ja) * | 2003-09-22 | 2010-05-26 | 久光製薬株式会社 | 低刺激性貼付剤 |
JP2008508227A (ja) * | 2004-07-29 | 2008-03-21 | サノフイ−アベンテイス | 高ph依存性溶解度を有する有効成分の放出制御のための医薬品多層錠剤 |
DK1836665T3 (da) * | 2004-11-19 | 2013-04-15 | Glaxosmithkline Llc | Fremgangsmåde til specialtilpasset afgivelse af medikamentkombinationsprodukter med variabel dosis til individualisering af terapier |
US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
WO2008112706A1 (en) | 2007-03-13 | 2008-09-18 | Nutrition 21, Inc. | Methods and compositions for the sustained release of chromium |
US8679541B2 (en) * | 2007-03-14 | 2014-03-25 | Particle Dynamics International, Llc | Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals |
WO2008128140A1 (en) * | 2007-04-13 | 2008-10-23 | The Regents Of The University Of Michigan | Delivery device and method for forming the same |
WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
CA3018328A1 (en) | 2014-10-31 | 2016-04-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
AU2017217466A1 (en) | 2016-02-11 | 2018-08-23 | Nutrition 21, Llc | Chromium containing compositions for improving health and fitness |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB768512A (en) * | 1954-08-16 | 1957-02-20 | Smith Kline & French Internat | Improvements in or relating to pharmaceutical tablets |
GB874586A (en) * | 1957-10-28 | 1961-08-10 | Upjohn Co | Improvements in or relating to therapeutic compositions and the manufacture thereof |
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
US3562257A (en) * | 1967-10-28 | 1971-02-09 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
GB1346610A (ja) * | 1971-07-02 | 1974-02-13 | ||
US3954959A (en) * | 1973-03-28 | 1976-05-04 | A/S Alfred Benzon | Oral drug preparations |
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
DE2802114A1 (de) * | 1978-01-19 | 1979-07-26 | Sandoz Ag | Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
IE48715B1 (en) * | 1978-12-22 | 1985-05-01 | Elan Corp Plc | New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
DE3124090A1 (de) * | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
DE3237575A1 (de) * | 1982-10-09 | 1984-04-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale mopidamolformen |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
US4567175A (en) * | 1983-06-03 | 1986-01-28 | Tanabe Seiyaku Co., Ltd. | 8-Chloro-1,5-benzothiazepine derivatives |
JPS6051106A (ja) * | 1983-08-31 | 1985-03-22 | Yamanouchi Pharmaceut Co Ltd | 塩酸アモスラロ−ル持続性製剤 |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
US4894240A (en) * | 1983-12-22 | 1990-01-16 | Elan Corporation Plc | Controlled absorption diltiazem formulation for once-daily administration |
JPS615010A (ja) * | 1984-06-18 | 1986-01-10 | Tooa Eiyoo Kk | 水素添加麦角アルカロイド徐放性製剤及びその製法 |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
DE3856555T2 (de) * | 1987-10-16 | 2004-04-29 | Elan Corp. Plc | Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
IL88083A (en) * | 1987-11-06 | 1992-11-15 | Tanabe Seiyaku Co | Controlled release pharmaceutical dosage form and its preparation |
FI101344B1 (fi) * | 1988-03-31 | 1998-06-15 | Tanabe Seiyaku Co | Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta |
DE3812799A1 (de) * | 1988-04-16 | 1989-10-26 | Sanol Arznei Schwarz Gmbh | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
-
1992
- 1992-05-20 AU AU20169/92A patent/AU2016992A/en not_active Abandoned
- 1992-05-20 AT AT92912145T patent/ATE120089T1/de active
- 1992-05-20 EP EP92912145A patent/EP0585355B1/en not_active Expired - Lifetime
- 1992-05-20 ES ES92912145T patent/ES2073301T3/es not_active Expired - Lifetime
- 1992-05-20 JP JP50028993A patent/JP3426230B2/ja not_active Expired - Lifetime
- 1992-05-20 DK DK92912145.7T patent/DK0585355T3/da active
- 1992-05-20 NZ NZ242806A patent/NZ242806A/en not_active IP Right Cessation
- 1992-05-20 WO PCT/US1992/004267 patent/WO1992020326A1/en active IP Right Grant
- 1992-05-20 DE DE69201793T patent/DE69201793T2/de not_active Expired - Lifetime
- 1992-12-22 US US07/995,309 patent/US5320853A/en not_active Expired - Lifetime
-
1995
- 1995-04-10 GR GR950400870T patent/GR3015737T3/el unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996019974A1 (fr) * | 1994-12-27 | 1996-07-04 | Kanebo, Ltd. | Preparation a liberation prolongee |
JP2007510676A (ja) * | 2003-11-13 | 2007-04-26 | レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 作用物質放出に関して調節作用のある物質を含有する、多層の剤形 |
JP2007510677A (ja) * | 2003-11-13 | 2007-04-26 | レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 調節性の物質の放出に影響を及ぼすマトリックスを有する多層の剤形 |
JP2009524698A (ja) * | 2006-01-27 | 2009-07-02 | ユーランド,インコーポレイテッド | 弱塩基性薬および有機酸を含む薬物送達系 |
JP2009524697A (ja) * | 2006-01-27 | 2009-07-02 | ユーランド,インコーポレイテッド | 弱塩基性選択性セロトニン5−ht3遮断剤および有機酸を含む薬物送達系 |
JP2013189455A (ja) * | 2006-01-27 | 2013-09-26 | Aptalis Pharmatech Inc | 弱塩基性薬および有機酸を含む薬物送達系 |
JP2013249305A (ja) * | 2006-01-27 | 2013-12-12 | Aptalis Pharmatech Inc | 弱塩基性選択性セロトニン5−ht3遮断剤および有機酸を含む薬物送達系 |
JP2016014048A (ja) * | 2006-01-27 | 2016-01-28 | アデア ファーマシューティカルズ,インコーポレイテッド | 弱塩基性選択性セロトニン5−ht3遮断剤および有機酸を含む薬物送達系 |
Also Published As
Publication number | Publication date |
---|---|
DE69201793D1 (de) | 1995-04-27 |
GR3015737T3 (en) | 1995-07-31 |
WO1992020326A1 (en) | 1992-11-26 |
ATE120089T1 (de) | 1995-04-15 |
EP0585355B1 (en) | 1995-03-22 |
DE69201793T2 (de) | 1995-09-21 |
DK0585355T3 (da) | 1995-06-06 |
NZ242806A (en) | 1994-01-26 |
JP3426230B2 (ja) | 2003-07-14 |
AU2016992A (en) | 1992-12-30 |
EP0585355A1 (en) | 1994-03-09 |
US5320853A (en) | 1994-06-14 |
ES2073301T3 (es) | 1995-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06507903A (ja) | 複数層の制御放出処方剤 | |
US5244925A (en) | Emulsion for parenteral administration | |
Lambert et al. | The actions of bismuth in the treatment of Helicobacter pylori infection | |
EP0287198B1 (en) | Mixtures of polar and neutral lipids for protecting the gastronointestinal tract | |
US4101650A (en) | Pepstatin floating minicapsules | |
SK130797A3 (en) | Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections | |
DE2551280A1 (de) | L-dopa-zubereitung | |
MXPA03009588A (es) | Un recubrimiento novedoso para una composicion farmaceutica de liberacion sostenida. | |
DE3115086A1 (de) | "dextromethorphan enthaltende pharamzeutische zusammensetzung und die verwendung von dextromethorphan zur schmerzbekaempfung" | |
JP5347195B2 (ja) | 殺菌剤、静菌剤及び抗炎症に関する方法と組成 | |
HUE026994T2 (en) | Liquid nasal spray containing low dose naltrexone | |
JPH0365324B2 (ja) | ||
JPH0577653B2 (ja) | ||
JP2006503905A (ja) | 炎症性サイトカインのレベルの増大と関連する病気および障害の治療のための方法および試薬 | |
EP0353267B1 (en) | Emulsion for parenteral administration | |
TW200529861A (en) | Methods and reagents for the treatment of inflammatory disorders | |
US4064230A (en) | Polyenic macrolide compositions | |
Holmes | Marine stingers in far north Queensland | |
Dubin et al. | Comparative effects of intrauterine instillation of analogues of quinacrine and tetracycline on uterine morphology in the rat | |
Farrell et al. | Experimental canine histoplasmosis with acute fatal and chronic recovered courses. | |
DE202012000910U1 (de) | Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität | |
AU624107B2 (en) | Emulsion for parenteral administration | |
JPH04134030A (ja) | 徐放性モルヒネ直腸投与製剤 | |
US3891752A (en) | Polyenic macrolide compositions and methods of use | |
JPS6028916A (ja) | アクラルビシンまたはその塩酸塩の油性組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080509 Year of fee payment: 5 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080509 Year of fee payment: 5 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080509 Year of fee payment: 5 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080509 Year of fee payment: 5 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090509 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100509 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100509 Year of fee payment: 7 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100509 Year of fee payment: 7 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100509 Year of fee payment: 7 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110509 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110509 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120509 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130509 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130509 Year of fee payment: 10 |